People Briefs: JenaValve CEO; Ortho-Clinical Changes; Baxter CFOs
This article was originally published in The Gray Sheet
JenaValve Technology names David Drachman as CEO. Ortho-Clinical Diagnostics makes executive changes following split from J&J. Baxter plans a CFO switch when it completes its biopharmaceutical company spinoff next year. More people news.
You may also be interested in...
Kidney dialysis and biosurgery will be two major focus points for a newly refined Baxter after it spins off its biopharmaceuticals business, as planned for mid-2015.
News Briefs: Medtronic’s CoreValve Approval; J&J Dx Unit Set For Sale; Google’s Glucometer Contact Lens
Medtronic gains FDA approval for its transcather CoreValve system months earlier than predicted. The Carlyle Group makes binding offer for J&J’s Ortho-Clinical Diagnostics business. Google is developing a wireless glucometer embedded within a contact lens. More news briefs.